Skip to main content

ResMed| statistics

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$33.29B
EV / EBITDA15.94
EV / sales5.81

Share price

Latest close$239.53
Day's change+0.3%
52-week high$277.67
52-week low$180.27
From 52-week high−13.7%
Return · 1 month+0.2%
Return · 3 months+4.9%
Return · year to date−0.6%
Return · 1 year−5.3%
Beta · 1 year against the S&P 5000.49
50-day average$232.16
200-day average$223.87
RSI 1452.5
Average volume · 20 sessions1.4M

Margins and returns

For fiscal 2026, as filed.

Gross margin61.1%
Operating margin33.4%
Net margin26.9%
Free cash flow margin29.2%
Return on equity24.3%
Return on assets17.5%
Return on invested capital23.6%
Return on capital employed25.6%
Stock-based compensation / revenue1.8%

Financial position

At the end of fiscal 2026.

Cash and equivalents$1.47B
Total debt$825.9M
Net debt−$643.3M
Current ratio3.10
Debt / equity0.13
Net debt / EBITDA−0.31

Shares and dividends

For fiscal 2026, as filed.

Diluted shares146M
Net share repurchases$625.5M
Dividends per share$2.40
Dividend payout23.0%

Taxes

For fiscal 2026, as filed.

Income tax expense$396.1M
Effective tax rate20.6%

RMD in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.